董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew Oakley | 男 | Independent Director | 63 | 未披露 | 2.00 | 2025-11-10 |
| Mattia Tomba | 男 | Independent Director | 46 | 未披露 | 2.00 | 2025-11-10 |
| Sukhvinder Gill | 男 | Chief Operating Officer and Director | 53 | 未披露 | 575.33 | 2025-11-10 |
| Gilbert H. Dunham, Jr. | 男 | Independent Director | 53 | 未披露 | 2.00 | 2025-11-10 |
| Timothy R. Ramdeen | 男 | Chairman of the Board and Chief Executive Officer | 34 | 未披露 | 575.33 | 2025-11-10 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sukhvinder Gill | 男 | Chief Operating Officer and Director | 53 | 未披露 | 575.33 | 2025-11-10 |
| Paul Sykes | 男 | Chief Financial Officer | 60 | 未披露 | 2.00 | 2025-11-10 |
| Timothy R. Ramdeen | 男 | Chairman of the Board and Chief Executive Officer | 34 | 未披露 | 575.33 | 2025-11-10 |
董事简历
中英对照 | 中文 | 英文- Andrew Oakley
-
Andrew Oakley自2018年6月起担任我们的首席财务官。在加入Autolus之前，奥克利先生于2017年2月至2018年6月担任Sosei Group的首席财务官，并于2017年8月至2018年6月担任其执行Vice President。从2015年1月至2016年6月，奥克利先生担任Vectura Group plc的首席财务官，公司秘书兼执行董事会成员。2003年1月至2013年8月，Oakley先生担任Actelion Ltd.的首席财务官。他此前也曾担任Accenture公司的全球控股公司的高级财务职务，也曾担任主要跨国建材公司的执行职务，也曾担任澳大利亚、英国和美国的银行的股票分析师数年。Oakley先生拥有Macquarie University经济学学士学位和London Business School工商管理硕士学位。Oakley先生是澳大利亚特许会计师协会的成员。
Andrew Oakley,one of Onconetix's directors and its Non-Executive Chairman since February 2025, is an experienced pharmaceutical and biotech industry professional. Previously, he held CFO positions at listed pharmaceutical companies Autolus Therapeutics plc (NASDAQ: AUTL) from 2018 to 2022 and Sosei Group (TSE:4565) from 2017 to 2018, as well as Vectura Group plc (LSE: VEC) and Actelion Ltd, where he led the finance function for over a decade. Additionally, he is a board member at a number of privately held biotech companies. Mr. Oakley holds a Bachelor of Economics Degree from Macquarie University and an MBA from London Business School and has been a Member of the Australian Institute of Chartered Accountants since 1987. - Andrew Oakley自2018年6月起担任我们的首席财务官。在加入Autolus之前，奥克利先生于2017年2月至2018年6月担任Sosei Group的首席财务官，并于2017年8月至2018年6月担任其执行Vice President。从2015年1月至2016年6月，奥克利先生担任Vectura Group plc的首席财务官，公司秘书兼执行董事会成员。2003年1月至2013年8月，Oakley先生担任Actelion Ltd.的首席财务官。他此前也曾担任Accenture公司的全球控股公司的高级财务职务，也曾担任主要跨国建材公司的执行职务，也曾担任澳大利亚、英国和美国的银行的股票分析师数年。Oakley先生拥有Macquarie University经济学学士学位和London Business School工商管理硕士学位。Oakley先生是澳大利亚特许会计师协会的成员。
- Andrew Oakley,one of Onconetix's directors and its Non-Executive Chairman since February 2025, is an experienced pharmaceutical and biotech industry professional. Previously, he held CFO positions at listed pharmaceutical companies Autolus Therapeutics plc (NASDAQ: AUTL) from 2018 to 2022 and Sosei Group (TSE:4565) from 2017 to 2018, as well as Vectura Group plc (LSE: VEC) and Actelion Ltd, where he led the finance function for over a decade. Additionally, he is a board member at a number of privately held biotech companies. Mr. Oakley holds a Bachelor of Economics Degree from Macquarie University and an MBA from London Business School and has been a Member of the Australian Institute of Chartered Accountants since 1987.
- Mattia Tomba
-
Mattia Tomba是Alchemy Investment Management的联合创始人和管理合伙人，Alchemy Investment Management是Alchemy Investments Acquisition Corp 1发起人的关联公司，自2021年10月27日起担任Alchemy Investments Acquisition Corp 1董事，自2022年11月起担任Alchemy Investments Acquisition Corp 1联席首席执行官。自2017年以来，他一直是Tradeteq的创始投资者和国际市场主管。他还是M & M Investments Pte.Ltd.的合伙人，该公司是一家控股公司，在全球范围内投资于科技公司，自2016年起提供债务和股权咨询。他是新加坡中东研究所（MEI）的研究员，2016年至2018年，通巴先生是高级研究员，2015年至2016年，通巴先生是MEI的访问高级研究员，主要研究亚洲与中东的关系。自2013年以来，他还担任塔夫茨大学弗莱彻学院主权财富和全球资本中心顾问委员会成员。Tomba先生在评估、谈判和安排全球范围内对公共和私人市场资本结构所有部分的直接投资方面有经验。通巴曾在卡塔尔主权财富基金（Qatari Diar）担任投资经理，在该基金管理股票投资组合，并在2008年至2016年期间参与全球大型私人股本和房地产交易。在此之前的2003年，通巴先生加入了高盛集团，在2008年之前，他参与了该银行管理的房地产基金的投资和投资组合管理。2002年，通巴在美林私人财富管理团队开始了他的私人股本和投资管理生涯。他曾在博科尼大学、政治学院和弗莱彻学院学习工商管理和国际事务。
Mattia Tomba,is the co-founder and managing partner of Alchemy Investment Management, an affiliate of Alchemy Investments Acquisition Corp 1 sponsor, and has been Alchemy Investments Acquisition Corp 1 director since October 27, 2021 and Alchemy Investments Acquisition Corp 1 co-CEO since November 2022. He has been a founding investor and the head of International Markets at Tradeteq since 2017. He has also been a Partner at M&M Investments Pte. Ltd., a holding company that invests in technology companies globally and provides debt and equity advice since 2016. He is a research affiliate at the Middle East Institute in Singapore (MEI), while from 2016 to 2018, Mr. Tomba was a senior fellow, and from 2015 to 2016, Mr. Tomba was a visiting senior fellow at MEI, where he focused on Asia—Middle East relations. He has also been sitting on the Advisory Council of the Center for Sovereign Wealth and Global Capital at The Fletcher School, Tufts University, since 2013. Mr. Tomba has experience in evaluating, negotiating, and structuring direct investments globally across all parts of the capital structure, in public and private markets. Mr. Tomba served as an Investment Manager at Qatar's Sovereign Wealth Fund (Qatari Diar), where he managed an equity portfolio and worked on large private equity and real estate transactions worldwide from 2008 to 2016. Prior to that, in 2003, Mr. Tomba joined the Goldman Sachs group, where he was involved in the investment and portfolio management of the real estate funds managed by the bank until 2008. Mr. Tomba began his private equity and investment management career in 2002 with the Private Wealth Management team of Merrill Lynch. He studied business administration and international affairs at Bocconi University, Sciences Po, and Fletcher School. - Mattia Tomba是Alchemy Investment Management的联合创始人和管理合伙人，Alchemy Investment Management是Alchemy Investments Acquisition Corp 1发起人的关联公司，自2021年10月27日起担任Alchemy Investments Acquisition Corp 1董事，自2022年11月起担任Alchemy Investments Acquisition Corp 1联席首席执行官。自2017年以来，他一直是Tradeteq的创始投资者和国际市场主管。他还是M & M Investments Pte.Ltd.的合伙人，该公司是一家控股公司，在全球范围内投资于科技公司，自2016年起提供债务和股权咨询。他是新加坡中东研究所（MEI）的研究员，2016年至2018年，通巴先生是高级研究员，2015年至2016年，通巴先生是MEI的访问高级研究员，主要研究亚洲与中东的关系。自2013年以来，他还担任塔夫茨大学弗莱彻学院主权财富和全球资本中心顾问委员会成员。Tomba先生在评估、谈判和安排全球范围内对公共和私人市场资本结构所有部分的直接投资方面有经验。通巴曾在卡塔尔主权财富基金（Qatari Diar）担任投资经理，在该基金管理股票投资组合，并在2008年至2016年期间参与全球大型私人股本和房地产交易。在此之前的2003年，通巴先生加入了高盛集团，在2008年之前，他参与了该银行管理的房地产基金的投资和投资组合管理。2002年，通巴在美林私人财富管理团队开始了他的私人股本和投资管理生涯。他曾在博科尼大学、政治学院和弗莱彻学院学习工商管理和国际事务。
- Mattia Tomba,is the co-founder and managing partner of Alchemy Investment Management, an affiliate of Alchemy Investments Acquisition Corp 1 sponsor, and has been Alchemy Investments Acquisition Corp 1 director since October 27, 2021 and Alchemy Investments Acquisition Corp 1 co-CEO since November 2022. He has been a founding investor and the head of International Markets at Tradeteq since 2017. He has also been a Partner at M&M Investments Pte. Ltd., a holding company that invests in technology companies globally and provides debt and equity advice since 2016. He is a research affiliate at the Middle East Institute in Singapore (MEI), while from 2016 to 2018, Mr. Tomba was a senior fellow, and from 2015 to 2016, Mr. Tomba was a visiting senior fellow at MEI, where he focused on Asia—Middle East relations. He has also been sitting on the Advisory Council of the Center for Sovereign Wealth and Global Capital at The Fletcher School, Tufts University, since 2013. Mr. Tomba has experience in evaluating, negotiating, and structuring direct investments globally across all parts of the capital structure, in public and private markets. Mr. Tomba served as an Investment Manager at Qatar's Sovereign Wealth Fund (Qatari Diar), where he managed an equity portfolio and worked on large private equity and real estate transactions worldwide from 2008 to 2016. Prior to that, in 2003, Mr. Tomba joined the Goldman Sachs group, where he was involved in the investment and portfolio management of the real estate funds managed by the bank until 2008. Mr. Tomba began his private equity and investment management career in 2002 with the Private Wealth Management team of Merrill Lynch. He studied business administration and international affairs at Bocconi University, Sciences Po, and Fletcher School.
- Sukhvinder Gill
-
Sukhvinder Gill，自2023年9月起担任RedCloud Technologies Limited的首席投资官。他最初于2022年11月加入公司担任高级副总裁。Gill先生为公司带来了30多年的金融市场和投资经验，并领导复杂的交易。在加入公司之前，Gill先生曾于2019年至2022年在日本跨国投资控股公司SoftBank Group Corp.担任风险投资家，担任投资副总裁。在那里，他的任务是寻找、为处于后期增长的私营公司进行尽职调查和执行投资。在软银任职期间，吉尔参与了多项交易，包括涉及JobandTalent、Jellysmack、OurCrowd、Better和Primary Bid的交易。他的角色还包括与投资组合公司就其增长战略进行合作。在软银任职之前，吉尔曾在交易所交易衍生品和场外交易市场担任交易员。在其职业生涯的早期，他曾在多家投资银行任职，包括摩根大通和DBS新加坡银行。随后，他在自营交易公司TransMarket Group担任董事总经理，专注于开发交易算法。随后，他管理了自己的家族办公室。Gill先生于1994年在伦敦国王学院获得商业管理理学学士学位（荣誉）。
Sukhvinder Gill,has been the Chief Investment Officer at RedCloud Technologies Limited since September 2023. He initially joined the Company as Senior Vice President in November 2022. Mr. Gill has to the Company over 30 years of experience in financial markets and investing, and leading complex transactions. Prior to joining the Company, Mr. Gill served in a venture capitalist role as Vice President of Investing at SoftBank Group Corp., a Japanese multinational investment holding company, from 2019 to 2022. While there, he was tasked with sourcing, conducting diligence for, and executing investments into late-stage growth private companies. During his time at SoftBank, Mr. Gill worked on several deals including those involving Jobandtalent, Jellysmack, OurCrowd, Better, and Primary Bid. His role also included working with portfolio companies on their growth strategies. Before his tenure at SoftBank, Mr. Gill worked as a trader in exchange-traded derivatives and the OTC markets. Earlier in his career, he held positions at various investment banks, including J.P. Morgan Chase and DBS Bank Singapore. He then served as Managing Director at the proprietary trading firm TransMarket Group, focusing on developing trading algorithms. Subsequently, he managed his own family office. Mr. Gill received his Bachelor of Science degree (Honours) in business management from King's College London in 1994. - Sukhvinder Gill，自2023年9月起担任RedCloud Technologies Limited的首席投资官。他最初于2022年11月加入公司担任高级副总裁。Gill先生为公司带来了30多年的金融市场和投资经验，并领导复杂的交易。在加入公司之前，Gill先生曾于2019年至2022年在日本跨国投资控股公司SoftBank Group Corp.担任风险投资家，担任投资副总裁。在那里，他的任务是寻找、为处于后期增长的私营公司进行尽职调查和执行投资。在软银任职期间，吉尔参与了多项交易，包括涉及JobandTalent、Jellysmack、OurCrowd、Better和Primary Bid的交易。他的角色还包括与投资组合公司就其增长战略进行合作。在软银任职之前，吉尔曾在交易所交易衍生品和场外交易市场担任交易员。在其职业生涯的早期，他曾在多家投资银行任职，包括摩根大通和DBS新加坡银行。随后，他在自营交易公司TransMarket Group担任董事总经理，专注于开发交易算法。随后，他管理了自己的家族办公室。Gill先生于1994年在伦敦国王学院获得商业管理理学学士学位（荣誉）。
- Sukhvinder Gill,has been the Chief Investment Officer at RedCloud Technologies Limited since September 2023. He initially joined the Company as Senior Vice President in November 2022. Mr. Gill has to the Company over 30 years of experience in financial markets and investing, and leading complex transactions. Prior to joining the Company, Mr. Gill served in a venture capitalist role as Vice President of Investing at SoftBank Group Corp., a Japanese multinational investment holding company, from 2019 to 2022. While there, he was tasked with sourcing, conducting diligence for, and executing investments into late-stage growth private companies. During his time at SoftBank, Mr. Gill worked on several deals including those involving Jobandtalent, Jellysmack, OurCrowd, Better, and Primary Bid. His role also included working with portfolio companies on their growth strategies. Before his tenure at SoftBank, Mr. Gill worked as a trader in exchange-traded derivatives and the OTC markets. Earlier in his career, he held positions at various investment banks, including J.P. Morgan Chase and DBS Bank Singapore. He then served as Managing Director at the proprietary trading firm TransMarket Group, focusing on developing trading algorithms. Subsequently, he managed his own family office. Mr. Gill received his Bachelor of Science degree (Honours) in business management from King's College London in 1994.
- Gilbert H. Dunham, Jr.
-
Gilbert H. Dunham，Jr.在金融、投资和投资组合管理方面拥有三十年的经验。他目前是A4 Partners的合伙人。他曾是注册投资顾问公司Bridgeway alth Partners的首席投资官，负责监督公共和私人投资。他曾在国际机构Hywin Capital Management担任董事总经理。他还是对冲基金配置平台Alternative Capital Advisers的首席信息官。他曾是一家多家族办公室的合伙人，负责投资组合管理。在此之前，他是私募股权基金Emigrant Capital的副总裁。在此之前，他是一家对冲基金集团的投资组合经理，在那里他成为种子，并推出了自己的多头/空头对冲基金。他的投资银行生涯始于贝尔斯登公司（Bear，Stearns & Co.，Inc.），担任电信集团分析师。邓纳姆先生毕业于达特茅斯学院，主修政府。领取了CFA、CAIA、CMT、QFA和CIC认定并拥有结构化产品方面的证书。邓纳姆还在多个州持有保险执照。他拥有FINRA的Series 7、69和78牌照。他是卡特负担网络的财务主席，也是一个非营利捐赠基金投资委员会的负责人。
Gilbert H. Dunham, Jr. three decades of experience in finance, investing and portfolio management. He is currently a Partner at A4 Partners. He was the Chief Investment Officer at Bridgeway alth Partners, a registered investment advisor, where he oversaw public and private investments. He was formerly a Managing Director with Hywin Capital Management, an international institution. He was also the CIO for Alternative Capital Advisers, a hedge fund allocation platform. He was a Partner at a multi family office responsible for portfolio management. Before that, he was a Vice President at Emigrant Capital, a private equity fund. Previo to that, he was a portfolio manager at a hedge fund group where he was seeded and launched his own long/short hedge fund. He began his career in investment banking at Bear, Stearns & Co., Inc. as an analyst in the telecommunications group. Mr. Dunham is a graduate of Dartmouth College where he majored in government. He has received his CFA, CAIA, CMT, QFA and CIC designations and has a certificate in structured products. Mr. Dunham also holds an insurance license in multiple states. He has the Series 7, 69 and 78 licenses from FINRA. He is the Finance Chair for the Carter Burden Network and is the head of the Investment Committee for a non profit endowment. - Gilbert H. Dunham，Jr.在金融、投资和投资组合管理方面拥有三十年的经验。他目前是A4 Partners的合伙人。他曾是注册投资顾问公司Bridgeway alth Partners的首席投资官，负责监督公共和私人投资。他曾在国际机构Hywin Capital Management担任董事总经理。他还是对冲基金配置平台Alternative Capital Advisers的首席信息官。他曾是一家多家族办公室的合伙人，负责投资组合管理。在此之前，他是私募股权基金Emigrant Capital的副总裁。在此之前，他是一家对冲基金集团的投资组合经理，在那里他成为种子，并推出了自己的多头/空头对冲基金。他的投资银行生涯始于贝尔斯登公司（Bear，Stearns & Co.，Inc.），担任电信集团分析师。邓纳姆先生毕业于达特茅斯学院，主修政府。领取了CFA、CAIA、CMT、QFA和CIC认定并拥有结构化产品方面的证书。邓纳姆还在多个州持有保险执照。他拥有FINRA的Series 7、69和78牌照。他是卡特负担网络的财务主席，也是一个非营利捐赠基金投资委员会的负责人。
- Gilbert H. Dunham, Jr. three decades of experience in finance, investing and portfolio management. He is currently a Partner at A4 Partners. He was the Chief Investment Officer at Bridgeway alth Partners, a registered investment advisor, where he oversaw public and private investments. He was formerly a Managing Director with Hywin Capital Management, an international institution. He was also the CIO for Alternative Capital Advisers, a hedge fund allocation platform. He was a Partner at a multi family office responsible for portfolio management. Before that, he was a Vice President at Emigrant Capital, a private equity fund. Previo to that, he was a portfolio manager at a hedge fund group where he was seeded and launched his own long/short hedge fund. He began his career in investment banking at Bear, Stearns & Co., Inc. as an analyst in the telecommunications group. Mr. Dunham is a graduate of Dartmouth College where he majored in government. He has received his CFA, CAIA, CMT, QFA and CIC designations and has a certificate in structured products. Mr. Dunham also holds an insurance license in multiple states. He has the Series 7, 69 and 78 licenses from FINRA. He is the Finance Chair for the Carter Burden Network and is the head of the Investment Committee for a non profit endowment.
- Timothy R. Ramdeen
-
Timothy R. Ramdeen自成立以来一直担任董事长兼首席执行官。Ramdeen先生是一位经验丰富的投资者和资本市场主管，拥有十多年的买方和咨询经验，涵盖对冲基金、私募股权和投资银行业务。在他的整个职业生涯中，他建立并领导了专注于事件驱动、结构化股权和特殊情况策略的投资平台，指导团队、管理机构投资组合，以及构建整个资本结构的复杂融资——包括SPAC、反向收购、PIPE、可转换证券、增长股权和混合债务交易。他监督和部署了数亿美元的总交易价值。Ramdeen先生是Hudson Strategic Advisors的创始人兼首席执行官，Hudson Strategic Advisors是一家总部位于纽约的投资银行和咨询平台，专注于新兴成长型和上市公司的特殊情况、信贷、结构性融资和资本形成。Ramdeen的职业生涯始于Brio Capital Management，担任投资团队的唯一分析师，负责小盘股上市公司的融资、承销和投资组合管理。除了投资和咨询方面的领导，Ramdeen先生还在多家公司的董事会和咨询委员会任职，其中包括Onconetix，Inc.（纳斯达克股票代码：ONCO），他是该公司审计和薪酬委员会的成员以及提名和公司治理委员会的主席。作为首席执行官，Ramdeen先生利用这种领导经验来识别和承保专有机会，将纪律严明的投资流程制度化，并通过严格的、事件驱动的执行来调整长期股东利益。Ramdeen先生拥有纽约大学Stern Biness学院的金融硕士学位和天普大学的生物学学士学位。他是FINRA授权的，拥有Series 79、63和SIE证书。
Timothy R. Ramdeen has served as Chairman and Chief Executive Officer since inception. Mr. Ramdeen is an experienced investor and capital markets executive with more than a decade of buy side and advisory experience spanning hedge funds, private equity, and investment banking. Throughout his career, he has built and led investment platforms foced on event driven, structured equity, and special situations strategies, directing teams, managing institutional portfolios, and structuring complex financings across the capital structure — including SPACs, reverse mergers, PIPEs, convertible securities, growth equity, and hybrid debt transactions. He has overseen and deployed hundreds of millions of dollars in aggregate transaction value. Mr. Ramdeen is the Founder and Chief Executive Officer of Hudson Strategic Advisors, a New York based investment banking and advisory platform foced on special situations, credit, structured financings, and capital formation for emerging growth and publicly listed companies.Mr. Ramdeen began his career at Brio Capital Management as the sole analyst on the investment team, responsible for scing, underwriting, and portfolio management across small cap public companies. In addition to his investing and advisory leadership, Mr. Ramdeen serves on the boards and advisory committees of multiple companies, including Onconetix, Inc. (NASDAQ: ONCO), where he is a member of the Audit and Compensation Committees and Chairman of the Nominating and Corporate Governance Committee. As Chief Executive Officer, Mr. Ramdeen leverages this leadership experience to identify and underwrite proprietary opportunities, institutionalize disciplined investment processes, and align long term shareholder interests through rigoro, event driven execution. Mr. Ramdeen holds an M.B.A. in Finance from New York University's Stern School of Biness and a B.S. in Biology from Temple University. He is FINRA licensed with Series 79, 63, and SIE credentials. - Timothy R. Ramdeen自成立以来一直担任董事长兼首席执行官。Ramdeen先生是一位经验丰富的投资者和资本市场主管，拥有十多年的买方和咨询经验，涵盖对冲基金、私募股权和投资银行业务。在他的整个职业生涯中，他建立并领导了专注于事件驱动、结构化股权和特殊情况策略的投资平台，指导团队、管理机构投资组合，以及构建整个资本结构的复杂融资——包括SPAC、反向收购、PIPE、可转换证券、增长股权和混合债务交易。他监督和部署了数亿美元的总交易价值。Ramdeen先生是Hudson Strategic Advisors的创始人兼首席执行官，Hudson Strategic Advisors是一家总部位于纽约的投资银行和咨询平台，专注于新兴成长型和上市公司的特殊情况、信贷、结构性融资和资本形成。Ramdeen的职业生涯始于Brio Capital Management，担任投资团队的唯一分析师，负责小盘股上市公司的融资、承销和投资组合管理。除了投资和咨询方面的领导，Ramdeen先生还在多家公司的董事会和咨询委员会任职，其中包括Onconetix，Inc.（纳斯达克股票代码：ONCO），他是该公司审计和薪酬委员会的成员以及提名和公司治理委员会的主席。作为首席执行官，Ramdeen先生利用这种领导经验来识别和承保专有机会，将纪律严明的投资流程制度化，并通过严格的、事件驱动的执行来调整长期股东利益。Ramdeen先生拥有纽约大学Stern Biness学院的金融硕士学位和天普大学的生物学学士学位。他是FINRA授权的，拥有Series 79、63和SIE证书。
- Timothy R. Ramdeen has served as Chairman and Chief Executive Officer since inception. Mr. Ramdeen is an experienced investor and capital markets executive with more than a decade of buy side and advisory experience spanning hedge funds, private equity, and investment banking. Throughout his career, he has built and led investment platforms foced on event driven, structured equity, and special situations strategies, directing teams, managing institutional portfolios, and structuring complex financings across the capital structure — including SPACs, reverse mergers, PIPEs, convertible securities, growth equity, and hybrid debt transactions. He has overseen and deployed hundreds of millions of dollars in aggregate transaction value. Mr. Ramdeen is the Founder and Chief Executive Officer of Hudson Strategic Advisors, a New York based investment banking and advisory platform foced on special situations, credit, structured financings, and capital formation for emerging growth and publicly listed companies.Mr. Ramdeen began his career at Brio Capital Management as the sole analyst on the investment team, responsible for scing, underwriting, and portfolio management across small cap public companies. In addition to his investing and advisory leadership, Mr. Ramdeen serves on the boards and advisory committees of multiple companies, including Onconetix, Inc. (NASDAQ: ONCO), where he is a member of the Audit and Compensation Committees and Chairman of the Nominating and Corporate Governance Committee. As Chief Executive Officer, Mr. Ramdeen leverages this leadership experience to identify and underwrite proprietary opportunities, institutionalize disciplined investment processes, and align long term shareholder interests through rigoro, event driven execution. Mr. Ramdeen holds an M.B.A. in Finance from New York University's Stern School of Biness and a B.S. in Biology from Temple University. He is FINRA licensed with Series 79, 63, and SIE credentials.
高管简历
中英对照 | 中文 | 英文- Sukhvinder Gill
Sukhvinder Gill，自2023年9月起担任RedCloud Technologies Limited的首席投资官。他最初于2022年11月加入公司担任高级副总裁。Gill先生为公司带来了30多年的金融市场和投资经验，并领导复杂的交易。在加入公司之前，Gill先生曾于2019年至2022年在日本跨国投资控股公司SoftBank Group Corp.担任风险投资家，担任投资副总裁。在那里，他的任务是寻找、为处于后期增长的私营公司进行尽职调查和执行投资。在软银任职期间，吉尔参与了多项交易，包括涉及JobandTalent、Jellysmack、OurCrowd、Better和Primary Bid的交易。他的角色还包括与投资组合公司就其增长战略进行合作。在软银任职之前，吉尔曾在交易所交易衍生品和场外交易市场担任交易员。在其职业生涯的早期，他曾在多家投资银行任职，包括摩根大通和DBS新加坡银行。随后，他在自营交易公司TransMarket Group担任董事总经理，专注于开发交易算法。随后，他管理了自己的家族办公室。Gill先生于1994年在伦敦国王学院获得商业管理理学学士学位（荣誉）。
Sukhvinder Gill,has been the Chief Investment Officer at RedCloud Technologies Limited since September 2023. He initially joined the Company as Senior Vice President in November 2022. Mr. Gill has to the Company over 30 years of experience in financial markets and investing, and leading complex transactions. Prior to joining the Company, Mr. Gill served in a venture capitalist role as Vice President of Investing at SoftBank Group Corp., a Japanese multinational investment holding company, from 2019 to 2022. While there, he was tasked with sourcing, conducting diligence for, and executing investments into late-stage growth private companies. During his time at SoftBank, Mr. Gill worked on several deals including those involving Jobandtalent, Jellysmack, OurCrowd, Better, and Primary Bid. His role also included working with portfolio companies on their growth strategies. Before his tenure at SoftBank, Mr. Gill worked as a trader in exchange-traded derivatives and the OTC markets. Earlier in his career, he held positions at various investment banks, including J.P. Morgan Chase and DBS Bank Singapore. He then served as Managing Director at the proprietary trading firm TransMarket Group, focusing on developing trading algorithms. Subsequently, he managed his own family office. Mr. Gill received his Bachelor of Science degree (Honours) in business management from King's College London in 1994.- Sukhvinder Gill，自2023年9月起担任RedCloud Technologies Limited的首席投资官。他最初于2022年11月加入公司担任高级副总裁。Gill先生为公司带来了30多年的金融市场和投资经验，并领导复杂的交易。在加入公司之前，Gill先生曾于2019年至2022年在日本跨国投资控股公司SoftBank Group Corp.担任风险投资家，担任投资副总裁。在那里，他的任务是寻找、为处于后期增长的私营公司进行尽职调查和执行投资。在软银任职期间，吉尔参与了多项交易，包括涉及JobandTalent、Jellysmack、OurCrowd、Better和Primary Bid的交易。他的角色还包括与投资组合公司就其增长战略进行合作。在软银任职之前，吉尔曾在交易所交易衍生品和场外交易市场担任交易员。在其职业生涯的早期，他曾在多家投资银行任职，包括摩根大通和DBS新加坡银行。随后，他在自营交易公司TransMarket Group担任董事总经理，专注于开发交易算法。随后，他管理了自己的家族办公室。Gill先生于1994年在伦敦国王学院获得商业管理理学学士学位（荣誉）。
- Sukhvinder Gill,has been the Chief Investment Officer at RedCloud Technologies Limited since September 2023. He initially joined the Company as Senior Vice President in November 2022. Mr. Gill has to the Company over 30 years of experience in financial markets and investing, and leading complex transactions. Prior to joining the Company, Mr. Gill served in a venture capitalist role as Vice President of Investing at SoftBank Group Corp., a Japanese multinational investment holding company, from 2019 to 2022. While there, he was tasked with sourcing, conducting diligence for, and executing investments into late-stage growth private companies. During his time at SoftBank, Mr. Gill worked on several deals including those involving Jobandtalent, Jellysmack, OurCrowd, Better, and Primary Bid. His role also included working with portfolio companies on their growth strategies. Before his tenure at SoftBank, Mr. Gill worked as a trader in exchange-traded derivatives and the OTC markets. Earlier in his career, he held positions at various investment banks, including J.P. Morgan Chase and DBS Bank Singapore. He then served as Managing Director at the proprietary trading firm TransMarket Group, focusing on developing trading algorithms. Subsequently, he managed his own family office. Mr. Gill received his Bachelor of Science degree (Honours) in business management from King's College London in 1994.
- Paul Sykes
Paul Sykes，于2021年4月至2025年5月期间担任Springbig Holdings，Inc.的首席财务官，该公司是一家在纳斯达克上市的大麻零售商SaaS平台，并通过de-SPAC合并领导该公司的公开上市。在加入SpringBig之前，Sykes先生于2018年2月至2020年7月担任Nordis Technologies的首席财务官和首席运营官，并于1997年至2017年担任DMG Information（一家总部位于美国、在伦敦证券交易所上市的DMGT PLC商业信息集团）的首席财务官。赛克斯先生的职业生涯始于英国毕马威会计师事务所。
Paul Sykes has served as Chief Financial Officer since July 2025. Mr. Sykes has served as the Chief Financial Officer of QDRO Acquisition Corp. since Augt 2025. In addition, Mr. Sykes served as Chief Financial Officer of Springbig Holdings, Inc. from April 2021 to May 2025, a Nasdaq listed SaaS platform for cannabis retailers, and led the company's public listing via a de SPAC merger. Prior to joining SpringBig, Mr. Sykes was Chief Financial Officer and Chief Operating Officer of Nordis Technologies from February 2018 through July 2020 and Chief Financial Officer of dmg information, the U.S. based biness information group of London stock exchange listed DMGT plc, from 1997 to 2017. Mr. Sykes started his career with KPMG in the United Kingdom.- Paul Sykes，于2021年4月至2025年5月期间担任Springbig Holdings，Inc.的首席财务官，该公司是一家在纳斯达克上市的大麻零售商SaaS平台，并通过de-SPAC合并领导该公司的公开上市。在加入SpringBig之前，Sykes先生于2018年2月至2020年7月担任Nordis Technologies的首席财务官和首席运营官，并于1997年至2017年担任DMG Information（一家总部位于美国、在伦敦证券交易所上市的DMGT PLC商业信息集团）的首席财务官。赛克斯先生的职业生涯始于英国毕马威会计师事务所。
- Paul Sykes has served as Chief Financial Officer since July 2025. Mr. Sykes has served as the Chief Financial Officer of QDRO Acquisition Corp. since Augt 2025. In addition, Mr. Sykes served as Chief Financial Officer of Springbig Holdings, Inc. from April 2021 to May 2025, a Nasdaq listed SaaS platform for cannabis retailers, and led the company's public listing via a de SPAC merger. Prior to joining SpringBig, Mr. Sykes was Chief Financial Officer and Chief Operating Officer of Nordis Technologies from February 2018 through July 2020 and Chief Financial Officer of dmg information, the U.S. based biness information group of London stock exchange listed DMGT plc, from 1997 to 2017. Mr. Sykes started his career with KPMG in the United Kingdom.
- Timothy R. Ramdeen
Timothy R. Ramdeen自成立以来一直担任董事长兼首席执行官。Ramdeen先生是一位经验丰富的投资者和资本市场主管，拥有十多年的买方和咨询经验，涵盖对冲基金、私募股权和投资银行业务。在他的整个职业生涯中，他建立并领导了专注于事件驱动、结构化股权和特殊情况策略的投资平台，指导团队、管理机构投资组合，以及构建整个资本结构的复杂融资——包括SPAC、反向收购、PIPE、可转换证券、增长股权和混合债务交易。他监督和部署了数亿美元的总交易价值。Ramdeen先生是Hudson Strategic Advisors的创始人兼首席执行官，Hudson Strategic Advisors是一家总部位于纽约的投资银行和咨询平台，专注于新兴成长型和上市公司的特殊情况、信贷、结构性融资和资本形成。Ramdeen的职业生涯始于Brio Capital Management，担任投资团队的唯一分析师，负责小盘股上市公司的融资、承销和投资组合管理。除了投资和咨询方面的领导，Ramdeen先生还在多家公司的董事会和咨询委员会任职，其中包括Onconetix，Inc.（纳斯达克股票代码：ONCO），他是该公司审计和薪酬委员会的成员以及提名和公司治理委员会的主席。作为首席执行官，Ramdeen先生利用这种领导经验来识别和承保专有机会，将纪律严明的投资流程制度化，并通过严格的、事件驱动的执行来调整长期股东利益。Ramdeen先生拥有纽约大学Stern Biness学院的金融硕士学位和天普大学的生物学学士学位。他是FINRA授权的，拥有Series 79、63和SIE证书。
Timothy R. Ramdeen has served as Chairman and Chief Executive Officer since inception. Mr. Ramdeen is an experienced investor and capital markets executive with more than a decade of buy side and advisory experience spanning hedge funds, private equity, and investment banking. Throughout his career, he has built and led investment platforms foced on event driven, structured equity, and special situations strategies, directing teams, managing institutional portfolios, and structuring complex financings across the capital structure — including SPACs, reverse mergers, PIPEs, convertible securities, growth equity, and hybrid debt transactions. He has overseen and deployed hundreds of millions of dollars in aggregate transaction value. Mr. Ramdeen is the Founder and Chief Executive Officer of Hudson Strategic Advisors, a New York based investment banking and advisory platform foced on special situations, credit, structured financings, and capital formation for emerging growth and publicly listed companies.Mr. Ramdeen began his career at Brio Capital Management as the sole analyst on the investment team, responsible for scing, underwriting, and portfolio management across small cap public companies. In addition to his investing and advisory leadership, Mr. Ramdeen serves on the boards and advisory committees of multiple companies, including Onconetix, Inc. (NASDAQ: ONCO), where he is a member of the Audit and Compensation Committees and Chairman of the Nominating and Corporate Governance Committee. As Chief Executive Officer, Mr. Ramdeen leverages this leadership experience to identify and underwrite proprietary opportunities, institutionalize disciplined investment processes, and align long term shareholder interests through rigoro, event driven execution. Mr. Ramdeen holds an M.B.A. in Finance from New York University's Stern School of Biness and a B.S. in Biology from Temple University. He is FINRA licensed with Series 79, 63, and SIE credentials.- Timothy R. Ramdeen自成立以来一直担任董事长兼首席执行官。Ramdeen先生是一位经验丰富的投资者和资本市场主管，拥有十多年的买方和咨询经验，涵盖对冲基金、私募股权和投资银行业务。在他的整个职业生涯中，他建立并领导了专注于事件驱动、结构化股权和特殊情况策略的投资平台，指导团队、管理机构投资组合，以及构建整个资本结构的复杂融资——包括SPAC、反向收购、PIPE、可转换证券、增长股权和混合债务交易。他监督和部署了数亿美元的总交易价值。Ramdeen先生是Hudson Strategic Advisors的创始人兼首席执行官，Hudson Strategic Advisors是一家总部位于纽约的投资银行和咨询平台，专注于新兴成长型和上市公司的特殊情况、信贷、结构性融资和资本形成。Ramdeen的职业生涯始于Brio Capital Management，担任投资团队的唯一分析师，负责小盘股上市公司的融资、承销和投资组合管理。除了投资和咨询方面的领导，Ramdeen先生还在多家公司的董事会和咨询委员会任职，其中包括Onconetix，Inc.（纳斯达克股票代码：ONCO），他是该公司审计和薪酬委员会的成员以及提名和公司治理委员会的主席。作为首席执行官，Ramdeen先生利用这种领导经验来识别和承保专有机会，将纪律严明的投资流程制度化，并通过严格的、事件驱动的执行来调整长期股东利益。Ramdeen先生拥有纽约大学Stern Biness学院的金融硕士学位和天普大学的生物学学士学位。他是FINRA授权的，拥有Series 79、63和SIE证书。
- Timothy R. Ramdeen has served as Chairman and Chief Executive Officer since inception. Mr. Ramdeen is an experienced investor and capital markets executive with more than a decade of buy side and advisory experience spanning hedge funds, private equity, and investment banking. Throughout his career, he has built and led investment platforms foced on event driven, structured equity, and special situations strategies, directing teams, managing institutional portfolios, and structuring complex financings across the capital structure — including SPACs, reverse mergers, PIPEs, convertible securities, growth equity, and hybrid debt transactions. He has overseen and deployed hundreds of millions of dollars in aggregate transaction value. Mr. Ramdeen is the Founder and Chief Executive Officer of Hudson Strategic Advisors, a New York based investment banking and advisory platform foced on special situations, credit, structured financings, and capital formation for emerging growth and publicly listed companies.Mr. Ramdeen began his career at Brio Capital Management as the sole analyst on the investment team, responsible for scing, underwriting, and portfolio management across small cap public companies. In addition to his investing and advisory leadership, Mr. Ramdeen serves on the boards and advisory committees of multiple companies, including Onconetix, Inc. (NASDAQ: ONCO), where he is a member of the Audit and Compensation Committees and Chairman of the Nominating and Corporate Governance Committee. As Chief Executive Officer, Mr. Ramdeen leverages this leadership experience to identify and underwrite proprietary opportunities, institutionalize disciplined investment processes, and align long term shareholder interests through rigoro, event driven execution. Mr. Ramdeen holds an M.B.A. in Finance from New York University's Stern School of Biness and a B.S. in Biology from Temple University. He is FINRA licensed with Series 79, 63, and SIE credentials.